ProfileGDS4718 / 244648_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 80% 78% 69% 73% 78% 68% 70% 71% 75% 76% 71% 80% 70% 67% 68% 71% 70% 73% 69% 86% 72% 73% 69% 80% 72% 67% 81% 83% 80% 75% 63% 72% 78% 73% 73% 75% 71% 78% 72% 65% 69% 72% 70% 69% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.8524580
GSM549102patient 115, normal, homogenized [OPG study]7.55378
GSM549104patient 119, normal, homogenized [OPG study]6.8075869
GSM549108patient 138, normal, homogenized [OPG study]7.1015273
GSM549119patient 077, normal, homogenized [OPG study]7.52478
GSM549133patient 032, cancer, homogenized [OPG study]6.7154968
GSM549139patient 042, cancer, homogenized [OPG study]6.8854370
GSM549099patient 107, normal, homogenized [OPG study]6.8645471
GSM549109patient 139, normal, homogenized [OPG study]7.3005475
GSM549110patient 046, normal, homogenized [OPG study]7.3777676
GSM549114patient 063, normal, homogenized [OPG study]6.9607771
GSM549122patient 082, normal, homogenized [OPG study]7.8872380
GSM549134patient 033, cancer, homogenized [OPG study]6.8311570
GSM549136patient 036, cancer, homogenized [OPG study]6.6841467
GSM549140patient 044, cancer, homogenized [OPG study]6.7533168
GSM549111patient 047, normal, homogenized [OPG study]7.0326271
GSM549113patient 057, normal, homogenized [OPG study]6.9157870
GSM549132patient 031, cancer, homogenized [OPG study]7.1254973
GSM549137patient 038, cancer, homogenized [OPG study]6.7868769
GSM549142patient 047, cancer, homogenized [OPG study]8.255786
GSM549100patient 110, normal, homogenized [OPG study]7.0221872
GSM549107patient 135, normal, homogenized [OPG study]7.1418473
GSM549115patient 068, normal, homogenized [OPG study]6.7866169
GSM549116patient 072, normal, homogenized [OPG study]7.9113680
GSM549120patient 078, normal, homogenized [OPG study]7.037972
GSM549131patient 030, cancer, homogenized [OPG study]6.6561667
GSM549118patient 074, normal, homogenized [OPG study]7.9738881
GSM549129patient 027, cancer, homogenized [OPG study]8.2455583
GSM549123patient 088, normal, homogenized [OPG study]7.8940180
GSM549124patient 006, cancer, homogenized [OPG study]7.3232975
GSM549126patient 015, cancer, homogenized [OPG study]6.352263
GSM549128patient 025, cancer, homogenized [OPG study]7.1623172
GSM549103patient 117, normal, homogenized [OPG study]7.5259978
GSM549117patient 073, normal, homogenized [OPG study]7.0709273
GSM549138patient 041, cancer, homogenized [OPG study]7.1779873
GSM549141patient 045, cancer, homogenized [OPG study]7.4770475
GSM549130patient 028, cancer, homogenized [OPG study]6.9037271
GSM549101patient 111, normal, homogenized [OPG study]7.6107778
GSM549105patient 128, normal, homogenized [OPG study]7.0646172
GSM549106patient 134, normal, homogenized [OPG study]6.5032765
GSM549112patient 048, normal, homogenized [OPG study]6.7797769
GSM549125patient 011, cancer, homogenized [OPG study]6.9883372
GSM549127patient 024, cancer, homogenized [OPG study]6.9806370
GSM549135patient 035, cancer, homogenized [OPG study]6.8153669